Intraoral Scanners Market Comprehensive Review of its Top Companies, Investment trend, Growth Opportunities, Drivers, Technology

Intraoral scanners market is forecasted to attain a size of $442.3 million by 2023.The growth in the intraoral scanners market will be led by increasing prevalence of dental problems, growing geriatric population, and improving accuracy and workflow of intraoral scanners. 

The end users in intraoral scanners market include hospitals and dental clinics. The demand for intraoral scanners in dental clinics is expected to witness fastest growth, at a CAGR of 10.5% during the forecast period, attributable to the increase in number of dental clinics as well as dentists doing private practice, globally.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/intraoral-scanners-market/report-sample

The APAC intraoral scanners industry is expected to witness the fastest growth in demand, at a CAGR of 11.2% during the forecast period, due to higher prevalence of dental problems, and aging population in the region. The growth of the APAC market is supported by rise in healthcare expenditure, strengthening economic condition, and growing pool of dental clinics and practitioners in various APAC countries such as China, Japan, and India. Further, rising awareness among general population about dental problems and the importance of their treatment is another a key factor supporting the market demand in the region.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=intraoral-scanners-market

Globally, key players in the intraoral scanners industry are developing and launching products that are equipped with latest advanced technology and offer various benefits such as enhanced functionality and portability to gain a larger market share. For instance, in March 2017, 3Shape A/S launched the TRIOS 3 Wireless – a wireless version of its TRIOS intraoral scanner. The 3Shape TRIOS 3 Wireless could connect cordlessly to laptops and the TRIOS cart and has three rechargeable batteries.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More

Read More

Agricultural Biotechnology Market-How it is Going to Impact on Farming Industry to Grow in Near Future

The agricultural biotechnology market size is projected to cross $55.5 million by 2023, growing at a CAGR of 10.1% during 2017-2023.

The market is growing mainly due to the increasing demand of agricultural biotechnology products include; the growing population size, rising per capita income, growing demand for biofuel, thriving demand for transgenic crops and regulatory support in the U.S. and Brazil.

The global agricultural biotechnology market in terms of product is bifurcated into transgenic seeds and crop protection products. Transgenic seeds accounted for the larger market share of 79.5% during the forecast period, attributed to their increasing adoption of these to prevent the impact of adverse climatic conditions such as droughts in the region. Also, rising global population is putting pressure on farmlands to produce more food, especially in developing countries such as India, China and given that the area under cultivation cannot be increased beyond a certain limit, the only way to increase production is through yield improvements, thus increasing the demand for transgenic seeds.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=agricultural-biotechnology-market

It has been observed that over the last decade biofuels have become a promising solution in solving environmental, and economic challenges associated with petroleum dependency and provide energy security. This increase in demand for fossil fuels is because it provides fuel security and produces less pollution, as compared to other conventional fossil fuels such as petroleum, coal and gas. Developed countries in the Europe and North America are beginning to see declines in liquid fuels consumption from the road transportation sector, due to increased vehicle fuel efficiency and growing interest in alternative fuel vehicles. For instance, according to the United States Department of Agriculture (USDA), EU-27 has a minimum target of 5.75% biofuel in 2010 and aims to increase it to 10.0%, by 2020. Also, the U.S. passed a Renewable Fuel Standard (RFS) in 2007 of 12 billion gallons of ethanol and 650 million gallons of biodiesel in 2010. The requirement for renewable fuel increases every year and it is expected to reach 36 billion gallons in 2022, further supporting the demand for agricultural biotechnology products and driving the growth of the agricultural biotechnology market.

Download Sample of This Research Report:  https://www.psmarketresearch.com/market-analysis/agricultural-biotechnology-market/report-sample

The Latin American market for agricultural biotechnology was valued at $10.1 billion and is expected to cross $21.9 billion by 2023, growing at a CAGR of 11.7% between 2017-2023. Brazil and Argentina are the major contributors in the agricultural biotechnology market in Latin American, characterized by the increasing production of transgenic products such as soybean and corn in these countries. Also, the rising adoption and production of transgenic crops is highly characterized by the growing support of government organizations in collaborating with private firms for the development of genetically modified crops.

Key players in the agricultural biotechnology market are entering into partnerships with other firms to improve their position in the market. For instance, November 2017, ADAMA Agricultural Solutions Ltd. and Ceradis B.V. entered into an R&D agreement to develop new, innovative and sustainable crop protection products based on ADAMA’s active ingredients and Ceradis’ technology.

Some of the key players operating in the agricultural biotechnology market include Syngenta AG, Performance Plants Inc., Monsanto Company, Certis USA LLC, BASF SE, Vilmorin & Cie, Evogene Ltd., ADAMA Agricultural Solutions Ltd., KWS SAAT SE, DowDuPont Inc., and Global Bio-chem Technology Group Company Limited.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More

Hepatitis Drugs Market Share Detailed Information Key Factors -Growth Potential, Opportunities, Drivers, Industry-Specific Challenges and Risks

The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.

The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market. According to the Hepatitis B Foundation, a non-profit organization solely dedicated to the global problem of hepatitis B, approximately 400 million people globally were chronically infected with hepatitis B, as reported at the end of September 2015.

Request to Get Free PDF Sample Copy

According to the World Health Organization (WHO), an estimated 130 - 150 million people globally were reported to suffer from hepatitis C, as of July 2015. The increasing incidences of hepatitis have increased the demand of therapeutic drugs for the management of diseases.

The key companies operating in the global hepatitis drugs market include Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma Corporation.

Read More....

Read More

Rapid Growth in Biopharmaceuticals Market Challenges and opportunities – Research Report

The global biopharmaceuticals market is increasing, due to growing aging population. In addition, the increasing healthcare investments   around the world are propelling the increase in R&D investments, which is fuelling the growth of the global biopharmaceuticals market. Furthermore, the increasing prevalence of chronic diseases due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity is also contributing to the growth in demand of biopharmaceuticals globally. On the basis of types, the global recombinant human insulin market segment is expected to witness fastest growth during the forecast period. Among the application segment,   the oncology segment accounted for the largest market in the global biopharmaceuticals market in 2014; and is expected to witness fastest growth, with 11.1% CAGR during the period 2015 – 2020.

The R&D investments in formulation and development of a drug have increased, due to the growing demand for prevention, treatment, and complete curative options for various diseases. Many pharmaceutical companies are focusing on developing more effective products to treat life-threatening diseases and encourage patients to live healthier lives with reduced disabilities. Also, the aging population is increasing rapidly around the world. The increasing aging population is propelling the growth of the global biopharmaceuticals market, as the pool of elder population is more prone to illness due to low immunity levels, and high recovery time consumption. The technological advancements in biopharmaceuticals have transformed treatment options for many diseases in the recent years. The technological advancements in biopharmaceuticals help to increase the chances of survival for cancer patients, curing hepatitis, and recovery of patients with arthritis.

Download Sample of This Research Report: 

However, the high cost and side effects of biopharmaceuticals is a key restraint, which is adversely impacting the growth of the global biopharmaceuticals market. In addition,   the entry of low cost biosimilars of existing biopharmaceuticals, also acts as a restraint in the growth of the global biopharmaceuticals market. The Asian biopharmaceuticals market is expected to witness fastest growth, with a CAGR of 10.6% during the period 2015 – 2020.

The key companies operating in the global biopharmaceuticals market include AbbVie Inc, Sanofi, Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AstraZeneca PLC, Novartis AG, Biogen Idec , Bristol-Myers Squibb Company and Amgen Inc.

Read More...

Read More

Benign Prostatic Hyperplasia (BPH) Procedures Market Identifies the Key Drivers of Growth and Challenges of the Key Industry Players

Benign Prostatic Hyperplasia (BPH) Procedures are expected to grow at a CAGR of 2.3% during 2017 – 2023, according to P&S Market Research.

Increasing life expectancy and fall in the birth rates are the major reasons for rise in the aging population. The people in this category require extensive care, since they are more prone to illness due to low immunity levels and longer recovery time. Increase in the aging population in the U.S., Germany, China and India in the next few years, is expected to create high demand for BPH treatment devices, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, prostate implants and laser based treatments. Thus, growing aging population acts as a strong driver supporting the increase in the number of BPH procedures performed.

According to the National Institute of Health, it has been estimated that around 14 million men in the U.S. had symptoms suggestive of BPH, which can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men aged more than 80 years. With 50% of men getting affected with BPH, there is a consequent increase in the BPH procedures.

As per the findings of the research, surgical procedure held the largest share in the global BPH procedures, primarily due to increasing prevalence of BPH disorders. The number of laser based procedure is expected to register fastest growth during the forecast period since these procedures are as effective as surgical procedures and reduce the hospital stay time. Hospitals held the largest share of the number of BPH procedures performed, based on the end user. Ambulatory surgical centers are expected to witness the highest inflow of BPH patients for treatment during the forecast period, due to development of technologically advanced BPH procedures and rising prevalence of BPH disorders leading to the growth in the number of patients treated in the ambulatory surgical centers.

Download Report Sample at: 

 

Geographically, Europe accounted for the largest number of BPH procedures done in 2016. Growing ageing population, lower cost of BPH treatment as compared to the U.S., high healthcare spending, and technological advancements in the field of urological procedures technology are some of the factors driving the growth of the BPH procedures in the Europe. France, Germany and the U.K. are expected to be the most promising countries for the growth in number of the BPH procedures. In June 2016, National Institute of Health and Care Excellence (NICE) approved GreenLight XPS laser treatment for the treatment of BPH. NICE added that the widespread adoption of the procedure could save the National Health Services (NHS) an estimated $4.3 million (£3 million) a year. Asia-Pacific is expected to witness the high number of BPH procedures performed during the forecast period, owing to the rising prevalence of BPH disorders, increasing disposable income, aging population, and growing efforts to increase awareness about advanced BPH treatment procedures.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=benign-prostatic-hyperplasia-procedures

There has been an increase in the use of minimally invasive procedures such as TUIP, laser based treatments, due to which several technological advancements are being done in the field of urology. Various treatment methods, such as the use of Rezum system and pulsed electromagnetic field therapy (PEMF), are being developed for the treatment of BPH. Rezum system manufactured by NxThera is a device that utilizes radiofrequency energy to create thermal energy in the form of water vapor to destroy excessive prostatic tissue growth caused by BPH, to resolve patient symptoms through a minimally invasive procedure, with few or no side effects.

  

Key players are in the process of introducing new advanced products for BPH treatment procedures. For instance, in May 2016, Olympus Corporation (Olympus), announced the launch of USFDA cleared Plasma-OvalButton, an addition to the company’s Plasma Loops and electrodes product portfolio that utilizes Olympus’ plasma technology for urologic procedures, including minimally invasive surgery to reduce benign prostate hyperplasia (BPH).

In March 2016, Lumenis Ltd. (Lumenis), announced the expansion of its comprehensive Urology portfolio with the launch of Lumenis Pulse 30H, at the European Association of Urology Congress, in Munich.

Some of the other key players operating in the global BPH procedures include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Karl Storz GmbH & Co. KG, Lumenis Ltd., Olympus Corporation, Advin Urology, Convergent Laser Technologies, Richard Wolf GmbH, Medtronic Plc.

GLOBAL BPH PROCEDURES SEGMENTATION

By Type

·         Surgical procedure

o    Transurethral resection of the prostate (TURP)

o    Transurethral incision of the prostate (TUIP)

·         Laser based procedure

o    Holmium lasers

o    Green light lasers

o    Thulium lasers

o    Others

·         Other energy based procedure

o    Transurethral microwave thermotherapy (TUMT)

o    Transurethral needle ablation (TUNA)

o    High-intensity focused ultrasound (HIFU) and water-induced thermotherapy

o    Others

By End User

·         Hospitals

·         Specialty clinics

·         Ambulatory surgery centers

By Geography

·         North America

o    The U.S.

o    Canada

·         Europe

o    France

o    Germany

o    The U.K.

o    Italy

o    Spain

o    Rest of Europe

·         Asia-Pacific

o    Australia

o    Japan

o    South Korea

o    Rest of Asia-Pacific

·         RoW

Read More

Laser Based Procedures is Expected to Account for the Largest Share in the U.S. BPH Procedures During the Forecast Period, 2017-2023

U.S. Benign Prostatic Hyperplasia (BPH) Procedures is expected to grow at a CAGR of 4.2% during 2017 - 2023

Increase in the aging population in the U.S in the next few years, is expected to create high demand for BPH treatments, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, TUIP and laser based treatments.  

According to the National Institute of Health, it has been estimated that around 14 million men in the U.S. had symptoms suggestive of BPH, which can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men aged more than 80 years. With 50% of men getting affected with BPH, there is a consequent increase in the BPH procedures.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/us-bph-procedures/report-sample

 As per the findings of the research, the different type of BPH treatment procedure include laser based procedures, surgical procedures, UroLift and other energy based procedures. Laser based procedures is expected to account for the largest share in the U.S. BPH procedures during the forecast period, since these procedures are more effective, as compared to the conventional procedures and are less likely to cause bleeding and other complications. Urolift is projected to register the fastest growth during the forecast period, mainly driven by the aging U.S. population, expanding insurance coverage of the procedure by various insurers, low cost of the procedure, and possibility of indication expansion of the UroLift procedure for the treatment of patients with BPH who have an obstructive median lobe.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=us-bph-procedures

Key player in the U.S. BPH procedures are acquiring other players to offer advanced products for BPH treatment procedures. For instance, in September 2017, Teleflex Incorporated, announced that the company has entered into definitive agreement with NeoTract, Inc. Under the terms of the agreement, Teleflex Incorporated agreed to acquire NeoTract, Inc. for a consideration of up to $1.1 billion. With this agreement, Teleflex Incorporated would be able to leverage the potential long-term benefits from NeoTracts, Inc. second generation UroLift system, which is expected to launch in the mid of 2018.

Some of the other key players providing products for BPH procedures in the U.S. include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Convergent Laser Technologies.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +18887787886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Read More